Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest
Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full acquisition. Read on for our thoughts on this and other updates here.
Fusion Antibodies: results underwhelmFusion Antibodies (LON: FAB), specialists in pre-clinical antibody discovery, for both therapeutic drug and diagnostic applications, underwhelmed with its interim results for the six months ending 30 September 2020, at least for a business with its high rating – the current market capitalisation is £29m. Revenues rose 8.5% of £1.90m with losses remaining stable at £0.47m. They expanded their R&D programme in the period by 50% to £271k to include a COVID-19 target along with their oncology targets, with the goal of using their Mammalian Antibody Library to produce neutralising antibodies against the virus. It would great…